Here are four points:
1. Analysts have set a 12-month consensus target price of $19.67 for the stock.
2. EndoChoice has a 12-month low of $7.37 and a 12-month high of $19.69.
3. The firm has a 50-day moving average of $8.92 and a 200-day moving average of $13.40.
4. The stock’s market cap is $205.05 million.
More articles on GI/endoscopy:
Offering Cologuard increases colonoscopy at USMD Health System
Torax Medical’s continence restoration system receives FDA clearance, Advanced Endoscopy Devices contracts with Premier & more – 4 GI/endoscopy company key notes
GI physician leader to know: Dr. Christine Carter-Kent of Medical University of South Carolina
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.